1. OLOBO, J.O., Handman, E., Curtis, J.M. and Mitchell, G.F. (1980). Antibodies to L.tropica promastigotes during infection in mice of various genotypes. The Australian Journal of Experimental Biology and Medical Sciences. 58: 595

 

2. OLOBO, J.O. and Black, S.J. (1990). Generation of bovine intraspecies hybridomas with initial suppressed growth. Vet. Immunol. Immunopath 24: 293

 

3. OLOBO, J.O. (1992). Reactivity of some monoclonal antibodies specific for human lymphocytes with the vervet monkey peripheral blood mononuclear cells. Scand. J. Immunol. 36 Suppl. 11, 199

 

4. OLOBO, J.O., Reid, G.D.F., Githure, J.I., Anjili, C.O. (1992). IFN- and delayed-type hypersensitivity are associated with cutaneous leishmaniasis in vervet monkeys following secondary rechallenge with Leishmania major. Scand. J. Immunol. 36, Suppl. 11, 48

 

5. Gicheru, M.M. and OLOBO, J.O. (1994). Evaluation of recombinant gp63, the major Leishmania surface glycoprotein, as a diagnostic molecule for leishmaniasis in vervet monkeys. Acta Tropica, 58: 345-348

6. OLOBO, J.O., Anjili, C.O., Githure, M.M., Mbati, P.A., Kariuki, T.M., Koech, D.K. and McMaster, W.R. (1995). Vaccination of vervet monkeys against cutaneous leishmaniasis using recombinant Leishmania major surface glycoprotein (gp63). Vet. Parasitol. 60:199-212.

 

7. Gicheru, M.M., OLOBO, J.O., Anjili, C.O., Ozwara, H.S. (1997). Heterologous protection by Leishmania donovani to Leishmania major in the vervet monkey. Exp. Parasitol. Exp. Parasitol. 85:109-116.

 

8. Gicheru MM, OLOBO JO, Anjili CO, Orago AS, Modabber M, Scott P. (2001). Vervet monkeys vaccinated with killed Leishmania major parasites and IL-12 develop a type 1 response, but are not protected against challenge infection. Infect. Immun. 69(1):245-251.

 

9. OLOBO, J.O., Mulu, G., Eguale, T., Getachew, A., Abebech, D., Ravn, P., and S. Britton (2001). Circulating TNF-, TGB-, and IL-10 in tuberculosis patients and household contacts. Scand. J. Immunol. 53 (1) 85-91

 

10. T. Mark Doherty, Abebech Demissie, JOSEPH OLOBO, Dawit Wolday, Sven Britton, Tewodros Eguale, Pernille Ravn and Peter Andersen (2002). Immune responses to the Mycobacterium tuberculosis-specific antigen ESAT-6 signal subclinical infection among contacts of tuberculosis patients. J. Clin. Microbiol., 40(2):704-706

 

11. OLOBO JO, Gicheru MM, Anjili CO. (2001). The African Green Monkey Model for Cutaneous and Visceral Leishmaniasis. Trends Parasitology, 40(2):588-592

 

12. Kidane, D., OLOBO, JO., Negesse, Y., Habre., Geletu. M., Yassin, A.M., Bereda, K., Azeb, T. W/G., Kifle, A., Harboe, M (2002). Identification of the causative organism of Tuberculous Lymphadenitis in Ethiopia by PCR. J. Clin Microbiol: 40: 4230-4234.

 

13. Yassin, M.A, OLOBO, J.O, Kidane, D., Negesse, Y., Shimeles, E., Tadesse, A., Demissie, A., Britton, S., Harboe, M., Aseffa, A., Abate, G (2003). Diagnosis of Tuberculous Lymphadenitis in Butajira, Rural Ethiopia. Scand. J. Infect Dis. 35: 1-4.

 

14. Charles Okori and JOSEPH OLOBO. (2008). Uganda. In Detecting Drug Resistant Malaria and Tuberculosis in Africa. Highlighting achievements of regional technical cooperation project RAF/6/025. Report of IAEA. Pg. 27.

 

15. Wayengera Misaki, Byarugaba Wilson, Kajumbula Henry, J. OLOBO, Kaddu Mulindwa (2009). A model for mapping of Ebola and Marburg RNA integration sites in rhesus Macaca mulatta genome in silico: Ebola virus acceptor sites located on chromosomes 4,6,7,8,9,14 and 15. Afr, J. Biotech 8(10): 2125-2130.

 

<- Go Back